Study: THC May Inhibit Growth of Endometrial Cancer

9-tetrahydrocannabinol (THC) may inhibit the migration of endometrial cancer cells, according to a study published by the journal Oncology Letters and epublished by the National Institute of Health.

“Limited therapeutic interventions are clinically available for treating aggressive endometrial cancer (EC)”, begins the study’s abstract. “Therefore, effective therapies are urgently required.” The present study “investigated the role of ∆9-tetrahydrocannabinol (THC), which is reported to impact proliferative and migratory activities during impairment of cancer progression.”

In the study, “cell migration in response to THC was measured using transwell assays. Using western blot analysis, the levels of cannabinoid receptors in EC tissues were detected and pathways leading to the inhibition of cell migration by THC on human EC cells were determined.”

Read moreStudy: THC May Inhibit Growth of Endometrial Cancer